European Archives - Page 169 of 999 - European Medical Journal

Implementation of Genomic Surveillance for Antimicrobial Resistance

AN ILLUMINATING session on the implementation of genomic surveillance for monitoring of antimicrobial resistance (AMR) patterns globally…

ESCMID 2024 Abstract Highlights

OVER the last 30 years, there has been a significant rise in both the number of solid organ transplant recipients, and the success rates…

Virtual Discovery of Immune-Stimulating Epitopes in Chikungunya Virus for Vaccine Design

Epitope identification is a key step in vaccine development, and this can be achieved much faster and less expensively with in silico…

The Future of Infection Treatment and Prevention in Immunocompromised Patients

THE emerging role of biological therapies in treating and preventing infection in patients who are immunocompromised was the primary focus…

Hand Washing Practices and Antibiotic Susceptibility of Palmar Bacterial Flora

Hand hygiene is one of the most effective and inexpensive means of preventing the spread of communicable diseases. Rates of handwashing…

a doctor listening to a patient's heartbeat

Hypertrophic Cardiomyopathy: Exploring Long-Term Data and Real-World Experiences

A summary of the pathophysiology and clinical manifestations of hypertrophic cardiomyopathy is presented, followed by a discussion on the challenges in managing HCM.

Active Surveillance Effective for Low-Risk Prostate Cancer

Active surveillance is an effective management strategy for males with favourable-risk prostate cancer, according to recent findings.

Ureteroscopy or Shockwave Lithotripsy for Kidney Stones in Children?

A study suggests that shockwave lithotripsy offers similar kidney stone clearance rates to ureteroscopy.

Proteomics Identifies Early Biomarkers for Hepatocellular Carcinoma

Research highlights the potential of proteomics in early detection of hepatocellular carcinoma and improving diagnostic accuracy.

New Surgical Platform Rapidly Identifies Isocitrate Dehydrogenase Mutations in Gliomas

A study reports of a new surgical platform capable of identifying isocitrate dehydrogenase mutations in gliomas in under two minutes.